Sema4’s Acquisition of GeneDx

Fenwick & West advised Sema4 on the deal.Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an OPKO…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now